Spectrum of MOG antibody-associated disorders. | Download Scientific Diagram
Clinical decision making in MOG antibody-associated disease - The Lancet Neurology
Pathology of myelin oligodendrocyte glycoprotein antibody–associated disease - Misu - 2021 - Clinical and Experimental Neuroimmunology - Wiley Online Library
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
Myelin oligodendrocyte glycoprotein antibodies in neurological disease | Nature Reviews Neurology
Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD) - ScienceDirect
Neurological update: MOG antibody disease | SpringerLink
Defining distinct features of anti-MOG antibody associated central nervous system demyelination - Martin S. Weber, Tobias Derfuss, Imke Metz, Wolfgang Brück, 2018
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature - ScienceDirect
Neuromyelitis Optica (NMO): What It Is, Symptoms & Treatment
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Presentation, Diagnosis, and Management | Pediatric Annals
Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype | Journal of Neuroinflammation | Full Text
MOG antibody demyelination | Great Ormond Street Hospital
MOG Antibody Disease - Practical Neurology
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? | Neurology Neuroimmunology & Neuroinflammation
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease - ScienceDirect
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
Novel MOG assay aids diagnosis of demyelinating diseases - Mayo Clinic
Myelin-oligodendrocyte glycoprotein antibody-associated disease - The Lancet Neurology
IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
What is MOGAD? | MOG Antibody Disease | SRNA
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder - ScienceDirect
The spectrum of MOG autoantibody-associated demyelinating diseases | Nature Reviews Neurology
